Patents by Inventor Amel Garnaoui

Amel Garnaoui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11559575
    Abstract: The invention relates to multi-epitopic peptide compounds obtained from PSA, HwB and LmLRAB proteins of Leishmania as well as to pharmaceutical compositions and vaccines for use against one or more leishmaniases.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: January 24, 2023
    Assignees: INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT, INSTITUT PASTEUR DE TUNIS
    Inventors: Rachel Bras Gonçalves, Jean-Loup Lemesre, Amel Garnaoui, Elodie Petitdidier-Lesin
  • Publication number: 20210213114
    Abstract: The invention relates to multi-epitopic peptide compounds obtained from PSA, HwB and LmLRAB proteins of Leishmania as well as to pharmaceutical compositions and vaccines for use against one or more leishmaniases.
    Type: Application
    Filed: May 29, 2019
    Publication date: July 15, 2021
    Applicants: INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT, INSTITUT PASTEUR DE TUNIS
    Inventors: Rachel Bras Gonçalves, Jean-Loup Lemesre, Amel Garnaoui, Elodie Petitdidier-Lesin
  • Publication number: 20110305667
    Abstract: The invention relates to the use of a DEAD-box RNA helicase from a yeast, a mammal, Leishmania infantum, or fragments thereof for inducing the production of cytokines by a peripheral blood mononuclear cell (PBMC) of a mammal, and to the applications thereof.
    Type: Application
    Filed: June 5, 2009
    Publication date: December 15, 2011
    Applicants: INSTITUT PASTEUR DE TUNIS, INSTITUT PASTEUR
    Inventors: Ikram Guizani, Mourad Barhoumi, Amel Garnaoui, Nolen Kyle Tanner